ELISA Kit for Interferon Beta (IFNb)

7.8-500pg/mL

The minimum detectable dose of this kit is typically less than 2.7pg/mL

3h

This assay has high sensitivity and excellent specificity for detection of Interferon Beta (IFNb).
No significant cross-reactivity or interference between Interferon Beta (IFNb) and analogues was observed.

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Interferon Beta (IFNb). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Interferon Beta (IFNb). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Interferon Beta (IFNb), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Interferon Beta (IFNb) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKε and DDX3.; Impaired TLR3/IFN-β signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: Relevance to the severity of liver damage; Training Modifies Innate Immune Responses in Blood Monocytes and in Pulmonary Alveolar Macrophages; Mannan binding lectin attenuates double-stranded RNA-mediated TLR3 activation and innate immunity; MicroRNA-30e* Suppresses Dengue Virus Replication by Promoting NF-κB–Dependent IFN Production; Complexes of DNA with the Antimicrobial Peptide LL37 Augment NK Cell Functions by Inducing Type I Interferon Production from Circulating Monocytes and Plasmacytoid Predendritic Cells; siRNA Targeting the 2A pro Genomic Region Prevents Enterovirus 71 Replication In Vitro; Cellular uptake of exogenous calcineurin B is dependent on TLR4/MD2/CD14 complexes, and CnB is an endogenous ligand of TLR4; Effects of IRF1 and IFN-β interaction on the M1 polarization of macrophages and its antitumor function; Host miR-146a promotes replication of human cytomegalovirus by suppressing type I IFN response in MRC-5 cells; MicroRNA-548j inhibits type I interferon production by targeting ZBTB11 in patients with chronic hepatitis B; Zika virus elicits inflammation to evade antiviral response by cleaving cGAS via NS1‐caspase‐1 axis; Evaluation of serum interferons in patients with age-related macular degeneration; Serodiagnosis of Human Bocavirus 1 Infection among Hospitalised Children with Lower Respiratory Tract Infection in Latvia; Scavenger receptor A impairs interferon response to HBV infection by limiting TRAF 3 ubiquitination through recruiting OTUB 1;